Cancel
Joseph R. Arron
Chief Scientific Officer
@
Sonoma BioTherapeutics
dp.yv6pp@zkeh3pwv4.f3f
Sign up to see email
Known information
- Earned a Ph.D. in immunology from The Rockefeller University
- Received an M.D. from Weill Medical College of Cornell University
- Completed undergraduate studies in chemistry at Princeton University
- Conducted postdoctoral research in developmental biology at Stanford University School of Medicine
- Previously served as the Chief Scientific Officer for Therapeutics at 23andMe
- Worked at Genentech for over 15 years, leading target discovery, preclinical development, and translational research for inflammatory, autoimmune, fibrotic, and ophthalmic disorders as Vice President of Immunology Research
- Has published more than 100 original articles
About Sonoma BioTherapeutics
Sonoma BioTherapeutics is a clinical-stage biotechnology company focused on developing engineered regulatory T cell therapies for autoimmune and inflammatory diseases, with proprietary technologies and a new manufacturing facility in Seattle.
Report inaccurate information
